CRL
Companies
Nyse American
Charles River Laboratories International, Inc.
Health Care
$145.29
-$39.31 (-21.29%)
Price Chart
Overview
About CRL
charles river provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. #drugdiscovery #biotech #biotechnology #pharmaceuticals #cro
Market Cap
$11.1B
Volume
149.7M
Avg. Volume
190.2M
P/E Ratio
13.112841
Dividend Yield
0.97%
Employees
17.2K
Company Information
Latest News for CRL
Charles River Laboratories' Q1 Earnings Beat Consensus, Stock Trades Higher On Signs Of Demand Stabilization
May 7, 2025
Activist Elliott reaches key agreement with Charles River. Here are three ways to create value
May 10, 2025
Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report?
June 6, 2025
Risk & Correlation Analysis
Market Correlation
1.19
Moderate Correlation
Volatility
Medium (0.37)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CRL shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$11.1B
Volume149.7M
P/E Ratio13.11
Dividend Yield0.97%
Important Dates
Next Dividend
Next Earnings
February 19, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025